Atlas FDA

OQY

11 FDA 510(k) clearances · Product code

116 daysmedian time to decision
230 days90th percentile
11clearances measured

FDA profile

Official device name
Intrauterine Tamponade Balloon
Device class
Class II (moderate risk)
Regulation
21 CFR 884.4530
Medical specialty
Obstetrics/Gynecology
FDA definition
provides temporary control or reduction of postpartum uterine bleeding
Adverse events (MAUDE)
2021: 113 · 2022: 274 · 2023: 228 · 2024: 215 · 2025: 180 · 2026: 59
Reports received by FDA, not confirmed device causation - volume tracks device popularity as much as risk.
Sort:Newest firstOldest first

Export predicate table (CSV) Shareable report ◉ Watch exports: 3 free/month · reports & watching: free

RecordFirmDate
Jada System (Jada-2002) (K253642)Organon, LLC2026-05-15
ELLAVI UBT (K230849)Sinapi Biomedical (Pty) , Ltd.2023-11-13
Bakri Essential Postpartum Balloon (K223098)Cook Incorporated2022-10-28
Jada System (K212757)Alydia Health2021-09-30
Jada System (K201199)Alydia Health2020-08-28
Every Second Matters-Uterine Balloon Tamponade (“ESM-UBT”) (K191264)Ujenzi Charitable Trust2019-10-30
Bakri Postpartum Balloon, Bakri Postpartum Balloon with Rapid Instillation Component (K170622)Cook Incorporated2017-03-31
ebb Complete Tamponade System (K153591)Clinical Innovations, LLC2016-01-14
ebb Complete Tamponade System (K150573)Clinical Innovations, LLC2015-03-25
BT-CATH (K101535)Utah Medical Products, Inc.2011-01-11
BELFORT-DILDY OBSTETRIC TAMPONADE SYSTEM (K091958)Glenveigh Surgical, LLC2010-04-30

Track OQY automatically

Every clearance here is in the API, with alerts when new ones post.